James E. Fickenscher
2018 - Zynerba Pharmaceuticals
In 2018, James E. Fickenscher earned a total compensation of $1.1M as Chief Financial Officer and Vice President, Corporate Development at Zynerba Pharmaceuticals, a 19% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $131,527 |
|---|---|
| Option Awards | $549,183 |
| Salary | $379,040 |
| Other | $46,335 |
| Total | $1,106,085 |
Fickenscher received $549.2K in option awards, accounting for 50% of the total pay in 2018.
Fickenscher also received $131.5K in non-equity incentive plan, $379K in salary and $46.3K in other compensation.
Rankings
In 2018, James E. Fickenscher's compensation ranked 8,703rd out of 14,244 executives tracked by ExecPay. In other words, Fickenscher earned more than 38.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,703 out of 14,244 | 39th |
Division Manufacturing | 3,471 out of 5,765 | 40th |
Major group Chemicals And Allied Products | 1,312 out of 2,128 | 38th |
Industry group Drugs | 1,097 out of 1,817 | 40th |
Industry Pharmaceutical Preparations | 855 out of 1,391 | 39th |
Source: SEC filing on April 25, 2019.
Fickenscher's colleagues
We found two more compensation records of executives who worked with James E. Fickenscher at Zynerba Pharmaceuticals in 2018.
News
Zynerba Pharmaceuticals CEO Armando Anido's 2022 pay slips 15% to $1.9M
April 21, 2023
Zynerba Pharmaceuticals CEO Armando Anido's 2021 pay jumps 49% to $2.2M
April 25, 2022
Zynerba Pharmaceuticals CEO Armando Anido's 2020 pay rises 8% to $1.5M
April 21, 2021
Zynerba Pharmaceuticals CEO Armando Anido's 2019 pay falls 32% to $1.4M
April 23, 2020
Zynerba Pharmaceuticals CEO Armando Anido's 2018 pay slips 18% to $2M
April 25, 2019